CurePath™

Start

Where you are in care today. This walk uses a sample path only — no names, dates of birth, or clinic records.

Screening

Sample: a Keep Cancer Away® screening visit for a new skin change on the left forearm. No patient identifiers.

Discovery

Sample: image-guided exam maps a superficial field on the left forearm, about 3 cm across. This is a synthetic finding for the walk.

Treatment doses

Sample plan: eight fractions of 4 Gy to that 3 cm skin field, image-guided at each visit. Not a prescription for a real person.

Organs at risk

Sample organs at risk for this field: nearby skin fold and the wrist joint. The sample plan keeps those structures outside the treated field.

Surveillance

Sample follow-up: a check at four weeks, then at three months, with photos and a toxicity review. Not clinic results.

Revise

The path updates when the plan or the monitoring changes. Sample revision: add a six-month surveillance visit after the three-month check.

• Treatment doses (revised) — the sample fraction count stays eight; the field edge is tightened.
• Surveillance (revised) — a six-month check is added.

Survive

Survivorship with CureRays — not a dead end after treatment.